Teva Pharmaceutical Industries Limited (TLV:TEVA)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue from Sale of Goods	14.60B	14.61B	14.05B
Revenue from Sale of Goods Growth	-0.03%	3.95%	8.25%
Licensing Arrangements Revenue	681.00M	678.00M	173.00M
Licensing Arrangements Revenue Growth	0.44%	291.91%	-74.60%
Distribution Revenue	1.56B	1.55B	1.58B
Distribution Revenue Growth	0.77%	-1.59%	-2.42%
Other Segment Revenue	504.00M	423.00M	745.00M
Other Segment Revenue Growth	19.15%	-43.22%	30.70%
Revenue (Other)	1.00M	1.00M	-
Revenue (Total)	17.35B	17.26B	16.54B
Revenue (Total) Growth	0.53%	4.32%	4.41%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States Revenue	8.81B	9.19B	8.03B
United States Revenue Growth	-4.08%	14.34%	3.92%
Europe Revenue	5.19B	5.04B	5.10B
Europe Revenue Growth	2.92%	-1.23%	5.50%
International Markets Revenue	2.10B	2.16B	2.46B
International Markets Revenue Growth	-2.68%	-12.22%	4.76%
Other Activities Revenue	1.25B	870.00M	944.00M
Other Activities Revenue Growth	43.33%	-7.84%	1.94%
Revenue (Total)	17.35B	17.26B	16.54B
Revenue (Total) Growth	0.53%	4.32%	4.41%

Adjusted EBIT by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States Segment Profit	3.33B	3.36B	2.30B
United States Segment Profit Growth	-0.74%	46.17%	-4.09%
Europe Segment Profit	1.38B	1.30B	1.58B
Europe Segment Profit Growth	5.53%	-17.27%	6.56%
International Markets Segment Profit	304.00M	336.00M	440.00M
International Markets Segment Profit Growth	-9.52%	-23.64%	-5.38%
Other Activities Segment Profit	-93.00M	-90.00M	18.00M
Other Activities Segment Profit Growth	-	-	-25.00%
Operating Income (Total)	2.29B	2.16B	-303.00M
Operating Income (Total) Growth	6.12%	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 16, 2026

Data Sources Report a data error